Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 Gag polyprotein is a major structural protein essential for the assembly, budding, and release of new virions from infected cells. It is encoded by the gag gene as a precursor protein (p55) and undergoes proteolytic cleavage to generate key structural components of the mature virus. Gag orchestrates virion assembly, membrane binding, genome packaging, budding, and maturation. Cleavage of Gag by the viral protease is critical for viral infectivity. Mutations within Gag can lead to antiretroviral drug resistance.
Protease inhibitors prevent Gag cleavage, leading to non-infectious virions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Gag Polyprotein (Gag).